Our Vision
NanoBiotec Co. provides ultra-sensitive and reliable bioassay services to monitor real-time protein and gene changes in minimal samples from cell culture, animals, and patients to accelerate discovery and development of new therapeutics.
Our Mission
NanoBiotec is a privately held contract research organization (CRO) dedicated to increasing the efficiency of discovering and developing novel therapeutic drugs. We provide cost-effective services to the biopharma industry, and academic investigators to accelerate development of novel drugs and personalized medicine for cancer, inflammation, and many other unmet diseases.
Our mission is to provide maximal information from a minuscule amount of samples and thus accelerate the translation of high-caliber innovations to therapeutics as efficiently as possible to benefit our patients today, rather than in the future.
Our Team
Our team has unparalleled drug discovery, bio-analytical, cytometric, genomic and proteomic expertise, harnessing the power of ultrasensitive nanoscale & multiplex immunoassays and microarrays. Our employees have been trained at world-class institutes such as MIT, NIH, MSKCC, Rutgers, Mount Sinai Medical School and worked over decades for multinational biopharma companies, including Novartis, Sanofi, Merck, BMS, Celgene, Regeneron. We obtain and interpret the data from multiple experiments to evaluate drug efficacy and address the potential mechanism of drugs and diseases.
Partnering
Our strategy is focused on building R&D partnerships with biotech, pharmaceutical, and diagnostic companies, as well as government and academic institutions. NanoBiotec is eager to consider proposals for R&D collaboration, strategic partnerships, and co-marketing arrangements. For additional information, please email to info@NanoBiotecUsa.com.
